FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to endocrinology, and concerns treatment and/or prevention of obesity or excessive body weight. For this purpose, causes of excessive weight are specified by analysing polymorphism of genes selected from line: LPL, GREL, INS, FABP2, ADRb3. Selection of diet and pharmacotherapy is carried out depending on versions of detected polymorphism.
EFFECT: method ensures efficient treatment of excessive body weight due to selection of adequate pharmaco- and diet-therapy for each individual patient.
9 cl, 24 dwg, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PANEL FOR DETERMINING PREDISPOSITION TO INCREASED BODY MASS INDEX, METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS AND ITS USE | 2024 |
|
RU2822360C1 |
| METHOD OF INDIVIDUAL DIETARY RECOMMENDATIONS FORMATION BASED ON DNA ANALYSIS | 2017 |
|
RU2691145C2 |
| METHOD OF TREATING METABOLIC SYNDROM | 2010 |
|
RU2452523C1 |
| METHOD FOR ESTIMATION OF INDIVIDUAL RISK OF EXCESSIVE BODY AND OBESITY DEVELOPMENT IN CHILDREN CONSUMING DRINKING WATER WITH INCREASED CHLOROFORM AND TETRACHLOROMETHANE CONTENT | 2016 |
|
RU2619872C1 |
| METHOD FOR TREATING PATIENTS WITH METABOLIC SYNDROME | 2017 |
|
RU2666288C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
| METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
| METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME WITH VITAMIN D DEFICIENCY | 2018 |
|
RU2694842C1 |
| METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
